Biocept
Latest round
- Series D
Last raised
- Jun 2006
Total raised
- $10M
Investors
- 1
About Biocept
Biocept, Inc.Biocept, Inc. specializes in liquid biopsy solutions aimed at cancer diagnostics.9 million shares at an exit price range of USD 10 to USD 12. The CEO, Michael Nall, leads the company, which has yet to report any significant pivots in strategy or operations.Biocept, Inc. specializes in the provision of innovative liquid biopsy solutions aimed at improving cancer detection and monitoring. Its core offerings include the Target Selector™ technology, which enables the extraction of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) from blood samples. This technology facilitates non-invasive cancer diagnostics, allowing healthcare professionals to obtain critical information about tumor characteristics and treatment responses without the need for traditional tissue biopsies. Biocept’s solutions are aimed at oncologists and laboratories, enhancing patient care through personalized treatment plans based on genetic insights.33 mn. The company operates on a fee-for-service model, providing diagnostic testing services to healthcare institutions and oncologists, who pay for each test performed using Biocept's proprietary technology.Biocept plans to enhance its product offerings with new diagnostic tests designed to improve cancer management and patient outcomes. The company is targeting expansion into additional international markets, with specific focus on regions in Europe and Asia to be established by 2025.
Who invested in Biocept
1 investor across 1 round
See all investors in Biocept
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jun 23, 2006
Amount
$10M
Investors
Questions about Biocept
Who invested in Biocept?
Biocept has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biocept raised?
Biocept has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Biocept last raise money?
Biocept's most recent round on record is a Series D, in Jun 2006.
What does Biocept do?
Biocept is a healthcare specialists company.
Where is Biocept headquartered?
Biocept is headquartered in San Diego, US.
Which VCs invest in companies like Biocept?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Biocept's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series D
Raising like Biocept? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.